Dr José Nasser MD PHD Substack

Dr José Nasser MD PHD Substack

Share this post

Dr José Nasser MD PHD Substack
Dr José Nasser MD PHD Substack
Depoimento de IVERMECTINA e FENBENDAZOL - Dois casos de câncer de sangue: paciente com leucemia mielóide aguda (LMA) torna-se "livre de câncer" e paciente com leucemia linfocítica crônica (LLC) melhor

Depoimento de IVERMECTINA e FENBENDAZOL …

Dr J Nasser MD and PHD
Jan 18

Share this post

Dr José Nasser MD PHD Substack
Dr José Nasser MD PHD Substack
Depoimento de IVERMECTINA e FENBENDAZOL - Dois casos de câncer de sangue: paciente com leucemia mielóide aguda (LMA) torna-se "livre de câncer" e paciente com leucemia linfocítica crônica (LLC) melhor
1

This thread is only visible to paid subscribers of Dr José Nasser MD PHD Substack

Subscribe to view →

Keep reading with a 7-day free trial

Subscribe to Dr José Nasser MD PHD Substack to keep reading this post and get 7 days of free access to the full post archives.

Already a paid subscriber? Sign in
© 2025 jose augusto nasser md phd
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture

Share